Viewpoint Molecular Targeting, Inc.

Funding and NIH signals

• NIH award NIH awarded $1.01M (STTR Phase II 4R42CA287696-02, extension, notice Sep 17, 2026). NIH RePORTER 4R42CA287696-02 (Sep 17, 2026)
  Evidence (1 event)

  • Sep 17, 2026 · NIH RePORTER 4R42CA287696-02
    Organization: VIEWPOINT MOLECULAR TARGETING, INC.; City/State: Coralville, IA; Project number: 4R42CA287696-02; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 1006109; Administering IC: National Cancer Institute; Project title: Antibody-based prertargeted alpha particle therapy for ovarian cancer; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals